Swedish experience with peritonectomy and HIPEC. HIPEC in peritoneal carcinomatosis

Annals of Surgical Oncology

Volumn 15, Issue 3, 2008, Pages 745-753

  Van Leeuwen, B L ^a   Graf, W ^a   Pahlman, L ^a   Mahteme, H ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

HIPEC; Peritoneal carcinomatosis; Peritonectomy

Indexed keywords

CAPECITABINE; CARBOPLATIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; FOLINATE CALCIUM; INTERFERON; MITOMYCIN C; OXALIPLATIN; PACLITAXEL;

ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; COLORECTAL CANCER; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; DRUG DOSE INCREASE; DRUG MEGADOSE; FEMALE; HEATED INTRAPERITONEAL CHEMOTHERAPY; HOSPITAL; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MESOTHELIOMA; MORBIDITY; NEUTROPENIA; OVARY CANCER; OVERALL SURVIVAL; PERITONECTOMY; PERITONEUM PSEUDOMYXOMA; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; STOMACH CANCER; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; MIDDLE AGED; MITOMYCIN; PERITONEAL NEOPLASMS; PERITONEUM; PLATINUM COMPOUNDS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SWEDEN;

EID: 39149110322     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9700-5     Document Type: Article

References (43)

1. Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 2000; 88:358-63
2. Gonzalez-Moreno S. Peritoneal surface oncology: a progress report. Eur J Surg Oncol 2006; 32:593-6
3. Murphy EM, Sexton R, Moran BJ. Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm. Dis Colon Rectum 2007; 50:37-42
4. Smeenk M, Verwaal VJ, Antonini N, et al. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg 2007; 245:104-9
5. Esquivel J, Sticca R, Sugarbaker P, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Ann Surg Oncol 2007; 14:128-33
6. Raspagliesi F, Kusamura S, Campos Torres JC, et al. Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: the experience of National Cancer Institute of Milan. Eur J Surg Oncol 2006; 32:671-5
7. Piso P, Dahlke MH, Loss M, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer. World J Surg Oncol 2004; 2:21
8. De Roover A, Detroz B, Detry O, et al. Adjuvant hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) associated with curative surgery for locally advanced gastric carcinoma. An initial experience. Acta Chir Belg 2006; 106:297-301
9. Fujimoto S, Takahashi M, Mutou T, et al. Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 1997; 79:884-91
10. Sugarbaker PH, Yan TD, Stuart OA, et al. Comprehensive management of diffuse malignant peritoneal mesothelioma. Eur J Surg Oncol 2006; 32:686-91
11. Begossi G, Gonzalez-Moreno S, Ortega-Perez G, et al. Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma. Eur J Surg Oncol 2002; 28:80-7
12. Natarajan N, Shuster TD. New agents, combinations, and opportunities in the treatment of advanced and early-stage colon cancer. Surg Clin North Am 2006; 86:1023-43
13. Sugarbaker PH. Peritonectomy procedures. Surg Oncol Clin N Am 2003; 12:703-727, XIII
14. Sarnaik AA, Sussman JJ, Ahmad SA, et al. Technology of intraperitoneal chemotherapy administration: a survey of techniques with a review of morbidity and mortality. Surg Oncol Clin N Am 2003; 12:849-63
15. Van Ruth S, Verwaal VJ, Zoetmulder FA. Pharmacokinetics of intraperitoneal mitomycin C. Surg Oncol Clin N Am 2003; 12:771-80
16. Elias DM, Sideris L. Pharmacokinetics of heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis. Surg Oncol Clin N Am 2003; 12:755-69, XIV
17. Elias DM, Pocard M. Treatment and prevention of peritoneal carcinomatosis from colorectal cancer. Surg Oncol Clin N Am 2003; 12:543-59
18. Harmon RL, Sugarbaker PH. Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol 2005; 2:3-13
19. NCI DHHS DTCD. Common terminology criteria for adverse events v3.0 (CTAE). Anonymous. Anonymous. Cancer Therapy Evaluation Program, 2006
20. Glehen O, Mithieux F, Osinsky D, et al. Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study. J Clin Oncol 2003; 21:799-806
21. Verwaal VJ, Van Tinteren H, Ruth SV, et al. Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 2004; 85:61-7
22. Stephens AD, Alderman R, Chang D, et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999; 6:790-96
23. Moran BJ. Establishment of a peritoneal malignancy treatment centre in the United Kingdom. Eur J Surg Oncol 2006; 32:614-8
24. Mahteme H, Hansson J, Berglund A, et al. Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study. Br J Cancer 2004; 90:403-7
25. Mahteme H, Graf W. Pseudomyxoma peritonei: a syndrome with varying prognosis. Läkartidningen 2003; 38:2936-40
26. Rouers A, Laurent S, Detroz B, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: higher complication rate for oxaliplatin compared to mitomycin C. Acta Chir Belg 2006; 106:302-6
27. Liberale G, Pocard M, Manganas D, et al. Hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis of digestive and peritoneal origin: rationale. Acta Chir Belg 2006; 106:291-6
28. Gilly FN. Phase II studies: International registry of colorectal carcinomatosis. Eur J Surg Oncol 2006; 32:648-54
29. Gomez PA, Barrios P, Rufian S, et al. Management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Eur J Surg Oncol 2006; 32:628-31
30. Goldberg RM, Tabah-Fisch I, Bleiberg H, et al. Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer. J Clin Oncol 2006; 24:4085-91
31. Verwaal VJ, Van Ruth S, Witkamp A, et al. Long-term survival of peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 2005; 12:65-71
32. Cavaliere F, Valle M, De Simone M, et al. 120 peritoneal carcinomatoses from colorectal cancer treated with peritonectomy and intra-abdominal chemohyperthermia: a S.I.T.I.L.O. multicentric study. In Vivo 2006; 20:747-50
33. Elias D, Benizri E, Di Pietrantonio D, et al. Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis. Ann Surg Oncol 2007; 14:509-14
34. Yonemura Y, Bandou E, Kawamura T, et al. Quantitative prognostic indicators of peritoneal dissemination of gastric cancer. Eur J Surg Oncol 2006; 32:602-6
35. Bristow RE, Tomacruz RS, Armstrong DK, et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002; 20:1248-59
36. Garcia-Carbonero R, Paz-Ares L. Systemic chemotherapy in the management of malignant peritoneal mesothelioma. Eur J Surg Oncol 2006; 32:676-681
37. Hadi R, Saunders V, Utkina O, et al. Review of patients with peritoneal malignancy treated with peritonectomy and heated intraperitoneal chemotherapy. ANZ J Surg 2006; 76:156-61
38. Gilly FN, Cotte E, Brigand C, et al. Quantitative prognostic indices in peritoneal carcinomatosis. Eur J Surg Oncol 2006; 32:597-601
39. Brigand C, Monneuse O, Mohamed F, et al. Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study. Ann Surg Oncol 2006; 13:405-12
40. Witkamp AJ, de Bree E, Van Goethem R, et al. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treat Rev 2001; 27:365-74
41. Verwaal VJ, Van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 21:3737-43
42. Schmidt U, Dahlke MH, Klemnauer J, et al. Perioperative morbidity and quality of life in long-term survivors following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 2005; 31:53-8
43. McQuellon RP, Loggie BW, Lehman AB, et al. Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol 2003; 10:155-62